BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) reported first half net profit to owners of company of 112.4 billion yen, down 40.0% from prior year. Earnings per share was 70.45 yen compared to 117.11 yen. Core operating profit was 639.2 billion yen, down 11.2%. Core EPS was 279 yen compared to 310 yen. For the six-month period ended September 30, 2025, revenue was 2.22 trillion yen, down 6.9% from previous year.
For fiscal year ending March 31, 2026, the company expects: basic earnings per share of 97.14 yen, and revenue of 4.5 trillion yen.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
